Search research articles
Contact Us
Filters
Showing results (171-180 of 222) with videos related to
Page
of 23
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 21, 2022
Vancomycin Pharmacokinetics in a Pregnancy Rat Model
Sean N Avedissian, Gwendolyn M Pais, Michelle Pham, et al.
Pharmacotherapy
|
January 17, 2023
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy
Erin F Barreto, Jack Chang, Matthew W Bjergum, et al.
Antimicrobial Agents and Chemotherapy
|
July 24, 2019
Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model
Medha D Joshi, Gwendolyn M Pais, Jack Chang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 10, 2023
Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
Todd A Miano, Rui Feng, Stephen Griffiths, et al.
The Journal of Antimicrobial Chemotherapy
|
March 25, 2015
Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis
Nathaniel J Rhodes, Bradley J Gardiner, Michael N Neely, et al.
Pharmacotherapy
|
August 7, 2016
Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation
Laura Whited, Meagan Grove, Dusten Rose, et al.
Antimicrobial Agents and Chemotherapy
|
January 4, 2019
Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR)
Sean N Avedissian, Nathaniel J Rhodes, Jiajun Liu, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2017
Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats
Nathaniel J Rhodes, Walter C Prozialeck, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2016
Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats
Nathaniel J Rhodes, Walter C Prozialeck, Thomas P Lodise, et al.
Annals of the Rheumatic Diseases
|
May 9, 2020
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
Maximilian F Konig, Alfred Hj Kim, Marc H Scheetz, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 222) with videos related to
Sort By:
Page
of 23
Antimicrobial Agents and Chemotherapy
|
April 21, 2022
Vancomycin Pharmacokinetics in a Pregnancy Rat Model
Sean N Avedissian, Gwendolyn M Pais, Michelle Pham, et al.
Pharmacotherapy
|
January 17, 2023
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy
Erin F Barreto, Jack Chang, Matthew W Bjergum, et al.
Antimicrobial Agents and Chemotherapy
|
July 24, 2019
Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model
Medha D Joshi, Gwendolyn M Pais, Jack Chang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 10, 2023
Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
Todd A Miano, Rui Feng, Stephen Griffiths, et al.
The Journal of Antimicrobial Chemotherapy
|
March 25, 2015
Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis
Nathaniel J Rhodes, Bradley J Gardiner, Michael N Neely, et al.
Pharmacotherapy
|
August 7, 2016
Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation
Laura Whited, Meagan Grove, Dusten Rose, et al.
Antimicrobial Agents and Chemotherapy
|
January 4, 2019
Understanding the Components, Calculation, and Impact of Monthly and Seasonal Variation of the Standardized Antimicrobial Utilization Ratio (SAAR)
Sean N Avedissian, Nathaniel J Rhodes, Jiajun Liu, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2017
Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats
Nathaniel J Rhodes, Walter C Prozialeck, Thomas P Lodise, et al.
Antimicrobial Agents and Chemotherapy
|
July 20, 2016
Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats
Nathaniel J Rhodes, Walter C Prozialeck, Thomas P Lodise, et al.
Annals of the Rheumatic Diseases
|
May 9, 2020
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
Maximilian F Konig, Alfred Hj Kim, Marc H Scheetz, et al.
Page
of 23